Question:
Selegine pharmacokinetics
Author: SuzukiAnswer:
Selegiline administered as the transdermal patch may produce less inhibition of gut and hepatic MAO at low doses because it avoids first-pass metabolism.
0 / 5 Â (0 ratings)
1 answer(s) in total